Cementos Pacasmayo ADR (NYSE:CPAC) Given Consensus Recommendation of “Hold” by Brokerages

Share on StockTwits

Shares of Cementos Pacasmayo ADR (NYSE:CPAC) have been assigned a consensus recommendation of “Hold” from the six research firms that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating and three have issued a buy rating on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $13.00.

Several research analysts recently weighed in on the stock. Zacks Investment Research cut shares of Cementos Pacasmayo from a “hold” rating to a “sell” rating in a report on Wednesday, July 17th. UBS Group raised shares of Cementos Pacasmayo from a “neutral” rating to a “buy” rating in a report on Wednesday, July 24th. Finally, ValuEngine downgraded shares of Cementos Pacasmayo from a “hold” rating to a “sell” rating in a report on Monday, July 29th.

Shares of Cementos Pacasmayo stock remained flat at $$8.17 during trading on Friday. The stock had a trading volume of 2 shares, compared to its average volume of 5,969. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.94 and a current ratio of 2.94. The stock has a 50 day moving average price of $8.71 and a two-hundred day moving average price of $9.24. The company has a market cap of $724.82 million, a price-to-earnings ratio of 22.08 and a beta of 0.80. Cementos Pacasmayo has a twelve month low of $8.00 and a twelve month high of $11.60.

Cementos Pacasmayo (NYSE:CPAC) last released its quarterly earnings data on Wednesday, July 17th. The construction company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.03. Cementos Pacasmayo had a return on equity of 7.79% and a net margin of 6.54%. The business had revenue of $96.91 million during the quarter, compared to analyst estimates of $92.25 million. On average, equities research analysts anticipate that Cementos Pacasmayo will post 0.49 EPS for the current fiscal year.

A hedge fund recently bought a new stake in Cementos Pacasmayo stock. Aperio Group LLC purchased a new position in shares of Cementos Pacasmayo ADR (NYSE:CPAC) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,161 shares of the construction company’s stock, valued at approximately $28,000. Hedge funds and other institutional investors own 3.98% of the company’s stock.

About Cementos Pacasmayo

Cementos Pacasmayo SAA., a cement company, produces, distributes, and sells cement and cement-related materials in the northern region of Peru. The company operates in three segments: Cement, Concrete and Blocks; Quicklime; and Sales of Construction Supplies. It produces cement for various uses, such as residential and commercial construction, and civil engineering; ready-mix concrete used in large construction sites; concrete blocks, such as paving units or paver stones for pedestrian walkways, as well as other bricks for partition walls and concrete blocks for structural and non-structural uses; and cement based products, including assembly gravity walls, beams and vaults, precast beams, sheet piles, seawalls, and piles, as well as bathroom and housing units.

Further Reading: What are defining characteristics of a correction?

Receive News & Ratings for Cementos Pacasmayo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cementos Pacasmayo and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nucor  Releases Q3 2019 Earnings Guidance
Nucor Releases Q3 2019 Earnings Guidance
Head-To-Head Review: Jerash Holdings   & Its Competitors
Head-To-Head Review: Jerash Holdings & Its Competitors
Analyzing Provectus Biopharmaceuticals  & Abbott Laboratories
Analyzing Provectus Biopharmaceuticals & Abbott Laboratories
Head to Head Comparison: Cyberark Software  vs. Red Violet
Head to Head Comparison: Cyberark Software vs. Red Violet
Ubiquiti  Cut to Hold at Zacks Investment Research
Ubiquiti Cut to Hold at Zacks Investment Research
Zacks Investment Research Lowers Stellus Capital Investment  to Sell
Zacks Investment Research Lowers Stellus Capital Investment to Sell


 
© 2006-2019 Zolmax.